Additional file 1: Table S1. of Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements

Number of cancer cases and distribution by socioeconomic disadvantage in New South Wales, Australia, 1996–2000 and 2004–2008. (DOCX 18 kb

Additional file 2: Table S2. of Cancer survival in New South Wales, Australia: socioeconomic disparities remain despite overall improvements

Stage distribution (%) by socioeconomic status for 10 cancers in NSW, Australia, 1996–2000 and 2004–2008. (DOCX 49 kb

Additional file 2: Table S4a. of Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks

Regression analysis of time trend after diagnosis using cause-specific mortality (Cox proportional hazard regression), relative survival (Poisson regression), and competing risk analysis (Fine-Gray regression), all cancers combined1, Australia NT, 1991–2009 (full model). Description: Table S4a. including hazard ratios for specific cancer sites. (DOC 47 kb

Additional file 1: Table S3a. of Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks

Regression analysis of cause-specific mortality (Cox proportional hazard regression), relative survival (Poisson regression), and competing risk (Fine-Gray regression), all cancers combined1, Australia NT, 1991–2009 (full model). Description: Table S3a. including hazard ratios for specific cancer sites. (DOC 49 kb

Additional file 1 of Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

Supplementary Tables. (PDF 88 kb

Additional file 2 of Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

Supplementary Figures. (ZIP 28672 kb

Demographic characteristics of Indigenous and non-Indigenous women’s Pap smears by abnormality, 2000–2011.

<p>Demographic characteristics of Indigenous and non-Indigenous women’s Pap smears by abnormality, 2000–2011.</p

Time trends in prevalence of cytology low-grade and histologically confirmed high-grade abnormalities by age-group, 2000–2011.

<p>Time trends in prevalence of cytology low-grade and histologically confirmed high-grade abnormalities by age-group, 2000–2011.</p

Characteristics of Indigenous and non-Indigenous women at their first recorded Pap smear.

<p>Characteristics of Indigenous and non-Indigenous women at their first recorded Pap smear.</p

Association of Indigenous status, calendar period, place of residence, area-level disadvantage and age with risk of cytology detected low-grade abnormalities and cytological and histological high-grade abnormalities including cervical cancer.

<p>Association of Indigenous status, calendar period, place of residence, area-level disadvantage and age with risk of cytology detected low-grade abnormalities and cytological and histological high-grade abnormalities including cervical cancer.</p